NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care. Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.
HCV Action good practice case study: Developing patient-centred care in Inverclyde and Renfrewshire
Inverclyde, in west central Scotland, has the highest estimated prevalence of problem drug use in Scotland (3.2% compared to a national average of 1.58%), while neighbouring Renfrewshire has the fourth highest in Scotland (2.41%). Both areas (which have above-average rates of deprivation) also have high hepatitis C prevalence rates, with many of those with the virus unaware of it.UK, Scotland Nov 2015 Case study PDF
Hepatitis C in London: 2015 report
This report, published by Public Health England, focuses on the epidemiology of hepatitis C in London, using the main routinely available surveillance data. It also provides recommendations for GPs; Directors of Public Health; local authorities and drug service commissioners; CCGs; NHS England; prison health service providers; drug services; PHE London, and laboratories on measures to prevent further infections and to reduce the morbidity and mortality of those already infected.Greater London Nov 2015 Reports & Research PDF
Briefing: Substance misuses services for men who have sex with men involved in chemsex
This briefing, published by Public Health England highlights issues relating to men who have sexual contact with other men (MSM) involved in chemsex. It contains background information, recent data, prompts for local areas and services, and case studies. With participation in chemsex increasing the likelihood of hepatitis C, hepatitis B and HIV transmission, the briefing is essential reading for commissioners and providers of drug and alcohol services .UK Nov 2015 Training, Reports & Research, Strategy & Planning PDF
Shooting Up: Infections among people who inject drugs in the UK 2014 - An update, November 2015
This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. Among its findings are that:
- Two in five of those people in the UK who inject psychoactive drugs are living with hepatitis C, with around half of these infections remaining undiagnosed.
- Changing patterns of psychoactive drug injection are increasing the risk of infection.UK, England, Northern Ireland, Scotland, Wales Nov 2015 Reports & Research PDF
HCV Action good practice case study: Going Viral project
This case-study looks at 'Going Viral', a week-long project ran across 9 hospitals which involved everyone in accident and emergency departments who was receiving a blood test also being offered a blood test for hepatitis C, hepatitis B and HIV - with the same blood sample being used.UK, England, Greater London Nov 2015 Case study PDF
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Birmingham on 23rd October 2015. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as suggested next steps to be taken in order to tackle hepatitis C more effectively in Birmingham and the wider West Midlands area.UK, West Midlands Nov 2015 Reports & Research PDF
Community case-finding strategies for viral hepatitis in UK migrant populations: the South East Coast England experience
This poster details the experiences of Frimley Park Hospital NHS Foundation Trust in their efforts to offer community-based testing to the South Asian and Nepali community in the population served by the hospital. It highlights the successes that can be achieved through engaging with religious leaders; ensuring peer mentor support, and encouraging word-of-mouth promotion through motivated community figures.UK, England, South East Oct 2015 Other, Reports & Research PDF
HCV Action and PHE hepatitis C roadshow in Birmingham: Presentations
On 23rd October HCV Action and Public Health England staged the third of their hepatitis C good practice roadshows in Birmingham, with the aim of instigating and assisting local action to tackle hepatitis C.UK, England, East Midlands, West Midlands Oct 2015 Other PDF
Hepatitis C Partnership South West Pilot: North Somerset 1 year update
In 2014, Addaction and The Hepatitis C Trust, with support from AbbVie, launched a unique pilot in the South West of England to encourage and widen access to hepatitis C testing and treatment among people who inject drugs. The initiative includes workforce development, peer-to-peer education and a buddying scheme. This briefing, focusing on work in North Somerset, presents early results from the pilot and sets out the next steps in its delivery.UK, England, South West Oct 2015 Other, Reports & Research PDF
National Clinical Guidelines for the treatment of HCV in adults
These guidelines provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness.
Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.Scotland Sep 2015 Other, Strategy & Planning PDF